Ptc Therapeutics (PTCT) EBITDA Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Ptc Therapeutics (PTCT) EBITDA Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -1,651.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,091.00 |
| 10 | Ptc Therapeutics | 5.79 Bn | 3.56 Bn | 340.60 Mn | 6,087.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,087.00 |
| Mar 31, 2026 | -6,600.00 |
| Dec 31, 2025 | 3,285.00 |
| Sep 30, 2025 | 2,913.00 |
| Jun 30, 2025 | 200.00 |
| Mar 31, 2025 | 10,413.00 |
| Dec 31, 2024 | -7,807.00 |
| Sep 30, 2024 | 3,241.00 |
| Jun 30, 2024 | 7,646.00 |
| Mar 31, 2024 | 3,174.00 |
| Dec 31, 2023 | 12,156.00 |
| Sep 30, 2023 | -2,871.00 |
| Jun 30, 2023 | -4,221.00 |
| Mar 31, 2023 | 480.00 |
| Dec 31, 2022 | -6,839.00 |
| Sep 30, 2022 | 3,568.00 |
| Jun 30, 2022 | 2,862.00 |
| Mar 31, 2022 | 2,505.00 |
| Dec 31, 2021 | 3,857.00 |
| Sep 30, 2021 | -2,052.00 |